NFKB1 and cancer: AURKA activates multiple oncogenic signaling pathways, including STAT3, NF-kB, and β-catenin, while suppressing critical tumor suppressor functions of p53 and TAp73 in cancer cells, promoting cancer cell survival and drug resistance [11,14,15].